Related references
Note: Only part of the references are listed.Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review
Rowan G. Casey et al.
EUROPEAN UROLOGY (2015)
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2014)
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer
Rene Ritter et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice
Bas W. G. van Rhijn et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk et al.
EUROPEAN UROLOGY (2013)
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Urinary cytology for the detection of urothelial carcinoma of the bladder-a flawed adjunct to cystoscopy?
Christian Bolenz et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
Severine Banek et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guerin
Colin P. N. Dinney et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy
H. Barton Grossman et al.
JOURNAL OF UROLOGY (2012)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
Flat urothelial carcinoma in situ of the bladder with glandular differentiation
Antonio Lopez-Beltran et al.
HUMAN PATHOLOGY (2011)
Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder
Hans-Martin Fritsche et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non-Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2010)
Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
Ingo Kausch et al.
EUROPEAN UROLOGY (2010)
Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features
Kurt B. Hodges et al.
HUMAN PATHOLOGY (2010)
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection
Yair Lotan et al.
BJU INTERNATIONAL (2009)
Carcinoma in situ of the Urinary Bladder: Review of Clinicopathologic Characteristics with an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis
Nalan Nese et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Immunocytology in the assessment of patients with asymptomatic hematuria
B. J. Schmitz-Draeger et al.
WORLD JOURNAL OF UROLOGY (2008)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
Bladder tumor markers beyond cytology:: International consensus panel on bladder tumor markers
VB Lokeshwar et al.
UROLOGY (2005)
Urine markers for bladder cancer surveillance: A systematic review
BWG van Rhijn et al.
EUROPEAN UROLOGY (2005)
A molecular signature in superficial bladder carcinoma predicts clinical outcome
L Dyrskjot et al.
CLINICAL CANCER RESEARCH (2005)
The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine
S Siracusano et al.
EUROPEAN UROLOGY (2005)
Risk stratification for bladdertumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology
SF Shariat et al.
EUROPEAN UROLOGY (2004)
A side by side comparison of cytology and biomarkers for bladder cancer detection
GL Schroeder et al.
JOURNAL OF UROLOGY (2004)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer
MF Sarosdy et al.
JOURNAL OF UROLOGY (2002)
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: A comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests
MG Friedrich et al.
JOURNAL OF UROLOGY (2002)
Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis
MP Raitanen et al.
EUROPEAN UROLOGY (2002)
Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder
C Mian et al.
UROLOGY (2000)
Share Paper
